BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Nemaura Announces Completion of SugarBEAT European Clinical Trial Programme and Positive Interim Results

  Nemaura announced the completion of its sugarBEAT European clinical trial programme and positive interim accuracy data.

  December 21, 2017

   · 

  3 min read
• 

  Business

  NuLife Sciences Chief Jumps Ship to Become Imaging3 CEO

  Imaging3 announced today that it has appointed John Hollister as CEO and chairman of the board.

  December 21, 2017

   · 

  4 min read
• FDA

  Aeterna Zentaris Announces FDA Approval of Macrilen (macimorelin) for Diagnosis of Adult Growth Hormone Deficiency

  AEterna Zentaris announced today that the FDA has granted marketing approval for Macrilen, an orally available ghrelin agonist, to be used in the diagnosis of patients with AGHD.

  December 21, 2017

   · 

  5 min read
• Drug Development

  Denali Therapeutics Announces Advancement and Expansion of Its LRRK2 Inhibitor Clinical Program for Parkinson’s Disease

  Based on a full review of the clinical data from this ongoing study, and additional preclinical data, the FDA has removed the previously imposed partial clinical hold.

  December 21, 2017

   · 

  4 min read
• Drug Development

  Innovation Pharma Completes Final Patient Visit in Phase IIb Study of Oral Prurisol for Psoriasis

  Innovation Pharma today announces all patient follow-up visits have been completed in its Phase 2b clinical study of oral Prurisol in moderate-to-severe chronic plaque psoriasis.

  December 21, 2017

   · 

  7 min read
• Drug Development

  Merck KGaA Release: FDA Grants Breakthrough Therapy Designation for Avelumab in Combination With INLYTA in Advanced Renal Cell Carcinoma

  Merck KGaA and Pfizer today announced that the FDA has granted Breakthrough Therapy Designation for avelumab in combination with INLYTA for treatment-naive patients with advanced renal cell carcinoma.

  December 21, 2017

   · 

  24 min read
• Business

  GW Pharma Announces the Appointment of Three New Independent Members to its Board of Directors

  GW Pharma today announced the appointment of three new independent members to its Board of Directors, bringing the GW Board to a total of eight members.

  December 21, 2017

   · 

  6 min read
• Biotech Beach

  BioSig Technologies Issues Shareholder Letter for 2017

  BioSig Technologies today announced that the Company has officially issued a letter to its shareholders providing them with updates on recent operational developments, industry trends, and strategic business prospects.

  December 21, 2017

   · 

  4 min read
• Job Trends

  KMT Hepatech Announces Expansion of Staff and Operations in Edmonton, AB, Canada

  KMT Hepatech, Inc. (“KMT”), a part of PhoenixBio group, announced plans to expand staff and operations by providing services with PXB-Mouse and starting the production of the PXB-Cells® – hepatocytes isolated from cDNA-uPA/SCID mice with highly humanized liver.

  December 21, 2017

   · 

  2 min read
• Policy

  Certara: A Proud Member of Medicines Development for Global Health’s (MDGH) NDA for River Blindness Team

  An Integrated Drug Development Team from CSC has been an integral part of MDGH’s development program and NDA for moxidectin.

  December 21, 2017

   · 

  5 min read